Figure S1A. Observed EQ-5D indexes for suspected pneumonia cases and non-diseased subjects during the one-year post-discharge period, excluding the CAP episode. Figure S2A. Survivors (%) in the diseased cohort (i.e. suspected pneumonia cases) and the non-diseased cohort during the one-year follow-up. Figure S3A. Mean EQ-5D-3 L-index, EQ-VAS and SF6D-index at different contact moments for the suspected CAP cases and the non-diseased subjects, respectively. Figure S4A. Profile of the population using EQ5D-instrument: Percentage reporting any problems per domain at different contact moments for A) the radiologically confirmed CAP cases and their non-diseased subjects, and B) the radiologically non-confirmed CAP cases and their non-diseased subjects, respectively. Figure S5A. SF-36 mean scale scores at different contact moments for A) the radiologically confirmed CAP cases and their non-diseased subjects, and B) the radiologically non-confirmed CAP cases and their non-diseased subjects, respectively. Figure S6A. Mean EQ-5D-3 L-index, EQ-VAS and SF6D-index at different contact moments for the radiologically confirmed CAP cases and their non-diseased subjects (A), and for the radiologically non-confirmed CAP cases and their non-diseased subjects (B). Table S1A. Exclusion criteria and reasons for nonparticipation in the “diseased” cohort of eligible suspected pneumonia episodes. Table S2A. Living situation, loss-to-follow up and deaths of suspected pneumonia cases and non-diseased subjects during the one-year follow-up. Table S3A. Spearman’s rho for EQ-VAS, EQ5D-index and SF6D-index at the different contact moments for suspected pneumonia cases. Table S4A. Spearman’s rho for EQ-VAS, EQ5D-index and SF6D-index at the different contact moments for non-diseased subjects. Table S5A. Baseline characteristics of radiologically confirmed and non-confirmed CAP cases and their non-diseased subjects. Table S6A. Living situation, loss-to-follow up and mortality of radiologically confirmed and non-confirmed CAP cases and their non-diseased subjects during the one-year follow-up. Table S7A. EQ5D-index, EQ-VAS and SF6D-index for the radiologically confirmed and non-confirmed CAP cases and their non-diseased subjects. Table S8A. Utility differences attributable to radiologically confirmed CAP and radiologically non-confirmed CAP, respectively. (DOCX 602 kb)